Infection Control News

In late May, the FDA announced approval of Moderna's mResvia, marking the third vaccine approved for respiratory syncytial virus and first time messenger RNA technology has been used for preventing a disease other than COVID-19.

SAN ANTONIO — The Association for Professionals in Infection Control and Epidemiology announced a new leadership program aimed at developing the next generation of infection preventionists.

The CDC announced a Salmonella outbreak that has spread to 25 states and left 162 people sick and 54 hospitalized was likely caused by recalled cucumbers.

Children in Massachusetts who were publicly insured or living in less affluent ZIP codes were less likely to receive nirsevimab, a monoclonal antibody for respiratory syncytial virus, according to research published in Pediatrics.

SAN ANTONIO — Natural language processing and other branches of AI are already being investigated for use in drug selection and diagnosis, and now researchers have found that AI may also help in infection prevention and surveillance.

Although nearly all health care facilities have antimicrobial-resistant bacteria, researchers are suggesting that pathogen reduction is a promising way to lessen the threat of transmission and risk of resistance.

SAN ANTONIO — We caught up with Connie Steed, MSN, RN, CIC, FAPIC, at the Association for Professionals in Infection Control and Epidemiology annual meeting to talk about the potential benefits of universal nasal decolonization.

Findings from a literature review published in Pediatrics provided more evidence that antimicrobial stewardship reduces antimicrobial use in NICUs without an increase in adverse events.

SAN ANTONIO — Clinicians at Memorial Sloan Kettering Cancer Center learned some valuable insight about environmental containment after they identified two patients with Candida auris.

The CDC has published guidance recommending that providers counsel certain patients on the harms and benefits of doxycycline for post-exposure prophylaxis — or doxy-PEP — for the prevention of sexually transmitted infections.